Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
7.28
-0.55 (-7.02%)
At close: Feb 21, 2025, 4:00 PM
7.38
+0.10 (1.37%)
After-hours: Feb 21, 2025, 5:41 PM EST
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $616.35 million as of February 21, 2025. Its market cap has decreased by -33.13% in one year.
Market Cap
616.35M
Enterprise Value
147.69M
1-Year Change
-33.13%
Ranking
Category
Stock Price
$7.28
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $616.35M, a decrease of -29.10%. That is a compound annual growth rate of -8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 616.35M | 29.08% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |